phenol has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
" We previously reported that relapsing remitting multiple sclerosis patients treated with dimethyl fumarate have a prominent depletion of the gut microbiota, thereby suggesting that studying the composition of plasma and CSF samples from these patients may help to identify microbially derived metabolites." | 4.12 | Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma. ( Amatruda, M; Button, J; Casaccia, P; Edwards, K; Frazier, C; Inbar, B; Kiebish, MA; Kim-Schulze, S; Lublin, F; Ntranos, A; Park, HJ; Tolstikov, V; Wentling, M, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ntranos, A | 1 |
Park, HJ | 1 |
Wentling, M | 1 |
Tolstikov, V | 1 |
Amatruda, M | 1 |
Inbar, B | 1 |
Kim-Schulze, S | 1 |
Frazier, C | 1 |
Button, J | 1 |
Kiebish, MA | 1 |
Lublin, F | 1 |
Edwards, K | 1 |
Casaccia, P | 1 |
1 other study available for phenol and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma.
Topics: Animals; Biomarkers; Dimethyl Fumarate; Humans; Indican; Multiple Sclerosis; Multiple Sclerosis, Rel | 2022 |